Abstract
Down Syndrome (DS) patients suffer from cognitive dysfunction, depression, hyperactivity, irritability etc. Dopamine (DA) and serotonin (5HT) are known to control cognitive and behavioral attributes. An increased number of the DA receptor 4 (DRD4) is detected in brain regions primarily involved in cognition. Impairments in executive function have also been reported with depletion in 5HT. A variable number of tandem repeat (VNTR) in the exon 3 of DRD4 and an insertion/deletion polymorphism in the promoter region of 5HT transporter (5HTTLPR) have been found to be associated with different neurobehavioral disorders; however, association of these polymorphisms with DS has never been explored. The present family-based analysis on DS revealed significant over-transmission of a DRD4 VNTR allele which encodes for D4 receptor with average activity. No association was noticed for the 5HTTLPR. We may conclude that these genetic polymorphisms are not contributing to the neuromotor and cognitive dysfunctions observed in DS.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Down JHL (1866) Observations on an ethnic classification of idiots. London Hospital Clin Lect Rep 3:259
Capone GT (2001) Down syndrome: advances in molecular biology and the neurosciences. J Dev Behav Pediatr 22:40–59
Epstein CJ (1990) The consequences of chromosome imbalance. Am J Med Genet 7:31–37
Korenberg JR, Chen XN, Schipper R et al (1994) Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc Natl Acad Sci USA 91:4997–5001
Nadel L (2003). Down syndrome: a genetic disorder in biobehavioral perspective. Genes Brain Behav 2:156–166
Soininen H, Partanen J, Jousmaki V et al (1993) Age-related cognitive decline and electroencephalogram slowing in Down’s syndrome as a model of Alzheimer’s disease. Neuroscience 53:57–63
Gibb WR, Mountjoy CQ, Mann DM, Lees AJ (1989) The substantia nigra and ventral tegmental area in Alzheimer’s disease and Down’s syndrome. J Neurol Neurosurg Psychiatr 52:193–200
Das Bhowmik A, Das M, Sinha S, Mukhopadhyay K (2007) Analysis of monoamine oxidase A promoter polymorphism in mentally retarded individuals. Psychiatr Genet 17:5
Deckert J, Catalano M, Syagailo YV et al (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621–624
Bladessarini RJ, Tarazi FI (1996) Brain dopamine receptors: a primer on their current status, basic and clinical. Harv Rev Psychiatr 3:301–325
Van Tol HHM, Bunzow JR, Guan HC et al (1992) Multiple dopamine D4 receptor variants in the human population. Nature 358:149–152
Miller EK (2000) The prefrontal cortex and cognitive control. Nat Rev Neurosci 1:59–65
Ridderinkhof RK, Ullsperger M, Crone EA, Nieuwenhuis S (2004) The role of medial frontal cortex in cognitive control. Science 306:443–447
Seeman P, Guan HC, Van Tol HHM (1993) Dopamine D4 receptors elevated in schizophrenia. Nature 365:441–445
Gelernter J, Kennedy JL, VanTol HH et al (1992) The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. Genomics 13:208–210
Lichter JB, Barr CL, Kennedy JL et al (1993) A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet 2:767–773
Asghari V, Sanyal S, Buchwaldt S et al (1995) Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 65:1157–1165
Serretti A, Cristina S, Lilli R et al (2002) Family-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disorders. Am J Med Genet 114B:361–369
Bhaduri N, Das M, Sinha S et al (2006) Association of dopamine D4 receptor (DRD4) polymorphisms with attention deficit hyperactivity disorder in Indian population. Am J Med Genet 141B:61–66
Ramamoorthy S, Bauman AL, Moore KR et al (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542–2456
Coyle JT, Oster-Granite ML, Gearhart JD. (1986) The neurobiologic consequences of Down syndrome. Brain Res Bull 16:773–787
Schickler M, Knobler H, Avraham KB et al (1989) Diminished serotonin uptake in platelets of transgenic mice with increased Cu/Zn-superoxide dismutase activity. EMBO J 8:1385–1392
Bazelon M, Barnet A, Lodge A, Shelboume SA (1968) The effect of high doses of 5-hydroxytryptophan on a patient with trisomy 21. Clinical, chemical and EEG correlations. Brain Res 11:397–411
Peter-Quadens O, DeGreef A (1971) Effects of 5-HTP on sleep in Mongol children. J Neurol Sci 13:115–119
Lesch KP, Bengel D, Heils A et al (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527–1531
Bengel D, Greenberg BD, Cora-Locatelli G et al (1999) Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder. Mol Psychiatry 4:463–466
Nobile M, Cataldo MG, Giorda G et al (2004) A case-control and family-based association study of the 5-HTTLPR in pediatric-onset depressive disorders. Biol Psychiatry 56:292–295
Banerjee E, Sinha S, Chatterjee A et al (2006) A family-based study of Indian subjects from Kolkata reveals allelic association of the serotonin transporter Intron-2 (STin2) polymorphism and attention deficit hyperactivity disorder. Am J Med Genet 141B:361–366
Guhathakurta S, Ghosh S, Sinha S, Chatterjee A et al (2006) Serotonin transporter promoter variants: analysis in Indian autistic and control individuals. Brain Res 1092:28–35
Heils A, Teufel A, Petri S et al (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621–2624
American Psychiatric Association (1994) Diagnostics and statistical manual of mental disorders [DSM-IV], 4th edn. Committee on Nomenclature and Statistics, Washington D.C
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16:1215–1224
Gelernter J, Kranzler H, Cubells JF (1997) Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Hum Genet 101:243–246
Dudbridge F (2003) Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115–221
Laird NM, Horvath S, Xu X (2000) Implementing a unified approach to family-based tests of association. Genet Epidemiol 19(Suppl 1):S36–S42 http://www.biostat.harvard.edu/~fbat/fbat.htm
Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149–150
Forgacs PB, Bodis-Wollner I (2004) Nicotinic receptors and cognition in Parkinson’s disease: the importance of neuronal synchrony. J Neural Transm 111:1317–1331
Samuels DC, Davis KL (1998) Experimental approaches to cognitive disturbance in Alzheimer’s disease. Harv Rev Psychiatr 6:11–22
Swanson JM, Sunohara GA, Kennedy JL et al (1998) Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder: a family-based approach. Mol Psychiatry 3:38–41
Kay AD, Schapiro MB, Riker AK et al (1987) Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down’s syndrome. Ann Neurol 21:408–411
Acknowledgement
Authors are thankful to all the families for their participation in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Das Bhowmik, A., Dutta, S., Sinha, S. et al. Lack of Association Between Down Syndrome and Polymorphisms in Dopamine Receptor D4 and Serotonin Transporter Genes. Neurochem Res 33, 1286–1291 (2008). https://doi.org/10.1007/s11064-007-9581-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-007-9581-9